Draft Genome Sequence of Bacillus amyloliquefaciens AP183 with Antibacterial Activity against Methicillin-Resistant Staphylococcus aureus

Shamima Nasrin; Mohammad J Hossain; Mark R Liles

doi:10.1128/genomeA.00162-15

Draft Genome Sequence of Bacillus amyloliquefaciens AP183 with Antibacterial Activity against Methicillin-Resistant Staphylococcus aureus

Genome Announc. 2015 Apr 16;3(2):e00162-15. doi: 10.1128/genomeA.00162-15.

Authors

Shamima Nasrin¹, Mohammad J Hossain¹, Mark R Liles²

Affiliations

¹ Department of Biological Sciences, Auburn University, Auburn, Alabama, USA.
² Department of Biological Sciences, Auburn University, Auburn, Alabama, USA lilesma@auburn.edu.

Abstract

Bacillus amyloliquefaciens AP183 expresses secondary metabolites that inhibit the growth of methicillin-resistant Staphylococcus aureus (MRSA). Here, we present a ~3.99-Mbp draft genome sequence of AP183 with the aims of providing insights into the genomic basis of its antibacterial mechanisms and exploring its potential use in preventing MRSA skin colonization.

Grants and funding

R44 AI085840/AI/NIAID NIH HHS/United States